SHARING IDEAS THAT DO GOOD

A new way to lower cost and delays in new drug development

post-image
Globally, all pharmaceutical companies face the same challenge of finding effective drug targets that will translate into higher drug approval rates. Hyperdrive Science technology increases the accuracy of, and cuts the time required for, drug candidate selection, reducing the costs of drug development. The technology takes advantage of naturally occurring processes that allow genomic information from a cell to be translated into its corresponding protein library to be tested for new and emergent drug targets. Hyperdrive Science has been supported by the ON Accelerate program at CSIRO. http://www.oninnovation.com.au/en/ON-teams/ON-Tribe/ON-Accelerate4-Teams/Hyperdrive
What do you think?

You must be logged in to post a comment.
Comments
Lynn Wood @ 2019.04.24 7:14 AM
Great idea to have more targeted trials of drugs that lead to better drug development.

Generic placeholder image

By rishadk

27 May 2019



Related Posts

Healthcare

post-image

The dark matter of the gut microbiome for future therapeutics
11 June 2021 by Mel Raassina 0 Comments

Healthcare

post-image

Genomic test pinpoints Covid19 risk
3 June 2021 by Marty 1 Comments

Healthcare

post-image

Bone repair innovations using aquaculture farms
31 May 2021 by Mel Raassina 0 Comments